NASDAQ:CASI

Delisted

Casi Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy CASI

*Your capital is at risk

$0.208

+0 (+0%)

At Close: May 22, 2026

56 Biggest Movers From Yesterday

12:00am, Wednesday, 24'th Oct 2018

CASI Pharma Reports Purchase Of HBV ANDA From Laurus Labs, No Terms Disclosed

12:00am, Tuesday, 23'rd Oct 2018

26 Stocks Moving In Thursday's Pre-Market Session

12:00am, Thursday, 04'th Oct 2018

CASI Pharmaceuticals Appoints Larry Zhang To President

12:00am, Tuesday, 02'nd Oct 2018

CASI Pharma Names George Chi CFO

12:00am, Friday, 28'th Sep 2018

Week In Review: WuXi AppTec Files For $1 Billion+ Hong Kong IPO At $13 Billion Valuation

12:00am, Sunday, 23'rd Sep 2018

CASI Pharmaceuticals Announces $48.5M Private Placement, Will Issue 9.048M Shares At Price Of $5.36/Share

12:00am, Friday, 14'th Sep 2018

Factors of Influence in —…–8, Key Indicators and Opportunity within Steelcase, ...

12:00am, Monday, 27'th Aug 2018

CASI Pharmaceuticals Q2 EPS $(0.12) Misses $(0.07) Estimate

12:00am, Tuesday, 14'th Aug 2018

CASI Pharma S-3 Shows Registration For Offering Of ~17.28M Shares Of Common Stock Via Selling Holders

12:00am, Tuesday, 17'th Jul 2018

Benzinga's Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index

12:00am, Thursday, 05'th Jul 2018

CASI Pharma Added To Russell 2000, 3000 And Microcap Indices

12:00am, Tuesday, 03'rd Jul 2018

44 Biggest Movers From Friday

12:00am, Monday, 02'nd Jul 2018

Casi Pharmaceuticals Stock News

56 Biggest Movers From Yesterday

CASI Pharma Reports Purchase Of HBV ANDA From Laurus Labs, No Terms Disclosed

26 Stocks Moving In Thursday's Pre-Market Session

CASI Pharmaceuticals Appoints Larry Zhang To President

CASI Pharma Names George Chi CFO

Week In Review: WuXi AppTec Files For $1 Billion+ Hong Kong IPO At $13 Billion Valuation

CASI Pharmaceuticals Announces $48.5M Private Placement, Will Issue 9.048M Shares At Price Of $5.36/Share

Factors of Influence in —…–8, Key Indicators and Opportunity within Steelcase, ...

CASI Pharmaceuticals Q2 EPS $(0.12) Misses $(0.07) Estimate

CASI Pharma S-3 Shows Registration For Offering Of ~17.28M Shares Of Common Stock Via Selling Holders

Benzinga's Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index

CASI Pharma Added To Russell 2000, 3000 And Microcap Indices

44 Biggest Movers From Friday

CASI Pharma Shares Fall ~7% Over Last Min., Not Seeing News To Justify Dip Lower; Shares Had Been Up ~10% For Session On No News

25 Stocks Moving In Monday's Pre-Market Session

Top Fintech Company